Brief: Eagle Pharmaceuticals Announces Financial Statements For Quarter Ended June 30, 2023 To No Longer Be Relied Upon
15/12/2023 23:30
Dec 15 (Reuters) - Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS- ON DEC 12,AUDIT COMMITTEE CONCLUDED
THAT
CO’S FINANCIAL STATEMENTS FOR QUARTER ENDED JUNE 30, 2023 SHOULD
NO LONGER BE RELIED UPON
* EAGLE PHARMACEUTICALS- COMPANY HAS IDENTIFIED MATERIAL
WEAKNESSES IN ITS INTERNAL CONTROL OVER FINANCIAL REPORTING THAT
EXISTED AS OF JUNE 30, 2023
Further company coverage: EGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq